POST Online Media Lite Edition


MoonLake Immunotherapeutics appoints chairman and director

Christian Fernsby |
Zug, Switzerland - MoonLake Immunotherapeutics AG, a clinical-stage biotechnology company, appoints Simon Sturge as chairman and Spike Loy to the board of directors.

Article continues below

Simon Sturge has 40 years of international leadership experience in the biotechnology and pharmaceutical industry.

Most recently, he was Chief Executive Officer of Kymab, a clinical-stage biopharmaceutical company developing fully human monoclonal antibodies with a focus on immunologic disease and immune-oncology, and was instrumental in its sale to Sanofi in early 2021.

Previously, Mr. Sturge served as Chief Operating Officer for Merck Healthcare, a division of Merck KGaA.

He has also held roles at Boehringer Ingelheim, Celltech Biologics and Ribotargets.

MoonLake also announced that Spike Loy, Managing Director of BVF Partners L.P. ("BVF") has been appointed a Member of the Board of Directors.

Mr. Loy has been a member of BVF's investment team since 2009.


Glencore appoints David Wormsley as director
Glencore appoints Kalidas Madhavpeddi as chairman
MoonLake Immunotherapeutics appoints Jorge Santos da Silva as CEO and Matthias Bodenstedt as CFO
iOnctura appoints Joanna Horobin as chair
WSSCC names Dominic O'Neill as executive director